Barclays Upgrades GlaxoSmithKline to Equal-Weight

Barclays analyst Emily Field upgrades GlaxoSmithKline (NYSE:GSK) from Underweight to Equal-Weight.

Barclays analyst Emily Field upgrades GlaxoSmithKline (NYSE:GSK) from Underweight to Equal-Weight.

Total
0
Shares
Related Posts